Matches in SemOpenAlex for { <https://semopenalex.org/work/W3211348839> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W3211348839 endingPage "1208" @default.
- W3211348839 startingPage "1203" @default.
- W3211348839 abstract "Background. Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are innovative drugs that effectively reduce glycemic levels and overweight in patients with type 2 diabetes mellitus (T2DM). However, the criteria for predicting the hypoglycemic effect of this group of drugs have not been practically defined.
 Aim. To assess the factors contributing to the achievement the glycemia normalization in patients with diabetes mellitus and obesity by adding to antihyperglycemic therapy (AT) a drug from the GLP-1 RA group liraglutide 3.0 mg per day.
 Materials and methods. A single-center, prospective, non-randomized study was provided. The objects of the study were patients with T2DM and obesity (n=22). Liraglutide 3.0 mg per day was added to the current AT of patients. Initially, the parameters of carbohydrate metabolism, hormones of the incretin system on an empty stomach and during the mixed-meal test, insulin resistance using the euglycemic hyperinsulinemic clamp test, and body composition were studied. After 9 months of therapy, all studies were repeated and a search for possible predictors of the carbohydrate metabolism normalization was made.
 Results. The body mass index of patients decreased from 42.4 [37.7; 45.0] to 35.9 [33.0; 40.9] kg/m2. Fasting blood glucose and glycated hemoglobin levels decreased from 9.02 [7.40; 11.37] mmol/L and 7.85 [7.43; 8.65]% up to 5.90 [5.12; 6.18] mmol/L and 6.40 [5.90; 6.60]%, respectively. 14 (63.6%) patients reached normoglycemia. Insulin resistance according to the clamp test did not change over the study. Basal concentrations of oxyntomodulin, glycentin and the area under the GLP-1, oxyntomodulin, glycentin curve significantly decreased 9 months after liraglutide administration. The prognostic marker of the achievement of normoglycemia during therapy with liraglutide 3.0 mg/day is the level of endogenous GLP-15.5 pmol/L before the appointment of arGPP-1 therapy.
 Conclusion. The concentration of endogenous GLP-1 before the appointment of liraglutide therapy at a dose of 3.0 mg per day can be used for prediction the drug hypoglycemic effect and achieving normoglycemia possibility." @default.
- W3211348839 created "2021-11-22" @default.
- W3211348839 creator A5040976739 @default.
- W3211348839 creator A5074863640 @default.
- W3211348839 date "2021-10-15" @default.
- W3211348839 modified "2023-09-26" @default.
- W3211348839 title "Prognostic factors for the carbohydrate metabolism normalization in patients with type 2 diabetes mellitus and obesity using liraglutide 3.0 mg per day" @default.
- W3211348839 cites W1998492206 @default.
- W3211348839 cites W2105912552 @default.
- W3211348839 cites W2527559853 @default.
- W3211348839 cites W2900780102 @default.
- W3211348839 cites W2902225118 @default.
- W3211348839 cites W3096156432 @default.
- W3211348839 cites W3114178858 @default.
- W3211348839 cites W3169576776 @default.
- W3211348839 cites W3204298406 @default.
- W3211348839 cites W4254445254 @default.
- W3211348839 doi "https://doi.org/10.26442/00403660.2021.10.201070" @default.
- W3211348839 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36286822" @default.
- W3211348839 hasPublicationYear "2021" @default.
- W3211348839 type Work @default.
- W3211348839 sameAs 3211348839 @default.
- W3211348839 citedByCount "0" @default.
- W3211348839 crossrefType "journal-article" @default.
- W3211348839 hasAuthorship W3211348839A5040976739 @default.
- W3211348839 hasAuthorship W3211348839A5074863640 @default.
- W3211348839 hasBestOaLocation W32113488391 @default.
- W3211348839 hasConcept C126322002 @default.
- W3211348839 hasConcept C134018914 @default.
- W3211348839 hasConcept C17093226 @default.
- W3211348839 hasConcept C2776398474 @default.
- W3211348839 hasConcept C2777180221 @default.
- W3211348839 hasConcept C2777391703 @default.
- W3211348839 hasConcept C2777538456 @default.
- W3211348839 hasConcept C2778881409 @default.
- W3211348839 hasConcept C2779306644 @default.
- W3211348839 hasConcept C2779357093 @default.
- W3211348839 hasConcept C2780221984 @default.
- W3211348839 hasConcept C2780473172 @default.
- W3211348839 hasConcept C2781308992 @default.
- W3211348839 hasConcept C2910068830 @default.
- W3211348839 hasConcept C555293320 @default.
- W3211348839 hasConcept C71315377 @default.
- W3211348839 hasConcept C71924100 @default.
- W3211348839 hasConcept C90924648 @default.
- W3211348839 hasConceptScore W3211348839C126322002 @default.
- W3211348839 hasConceptScore W3211348839C134018914 @default.
- W3211348839 hasConceptScore W3211348839C17093226 @default.
- W3211348839 hasConceptScore W3211348839C2776398474 @default.
- W3211348839 hasConceptScore W3211348839C2777180221 @default.
- W3211348839 hasConceptScore W3211348839C2777391703 @default.
- W3211348839 hasConceptScore W3211348839C2777538456 @default.
- W3211348839 hasConceptScore W3211348839C2778881409 @default.
- W3211348839 hasConceptScore W3211348839C2779306644 @default.
- W3211348839 hasConceptScore W3211348839C2779357093 @default.
- W3211348839 hasConceptScore W3211348839C2780221984 @default.
- W3211348839 hasConceptScore W3211348839C2780473172 @default.
- W3211348839 hasConceptScore W3211348839C2781308992 @default.
- W3211348839 hasConceptScore W3211348839C2910068830 @default.
- W3211348839 hasConceptScore W3211348839C555293320 @default.
- W3211348839 hasConceptScore W3211348839C71315377 @default.
- W3211348839 hasConceptScore W3211348839C71924100 @default.
- W3211348839 hasConceptScore W3211348839C90924648 @default.
- W3211348839 hasIssue "10" @default.
- W3211348839 hasLocation W32113488391 @default.
- W3211348839 hasLocation W32113488392 @default.
- W3211348839 hasLocation W32113488393 @default.
- W3211348839 hasOpenAccess W3211348839 @default.
- W3211348839 hasPrimaryLocation W32113488391 @default.
- W3211348839 hasRelatedWork W138803513 @default.
- W3211348839 hasRelatedWork W1986132654 @default.
- W3211348839 hasRelatedWork W2005919381 @default.
- W3211348839 hasRelatedWork W2026316039 @default.
- W3211348839 hasRelatedWork W2032225465 @default.
- W3211348839 hasRelatedWork W2125102063 @default.
- W3211348839 hasRelatedWork W2144299763 @default.
- W3211348839 hasRelatedWork W2912137655 @default.
- W3211348839 hasRelatedWork W3211348839 @default.
- W3211348839 hasRelatedWork W2885933730 @default.
- W3211348839 hasVolume "93" @default.
- W3211348839 isParatext "false" @default.
- W3211348839 isRetracted "false" @default.
- W3211348839 magId "3211348839" @default.
- W3211348839 workType "article" @default.